top of page
Create Your First Project
Start adding your projects to your portfolio. Click on "Manage Projects" to get started
X4 Pharmaceuticals
Date
August 2022 - October 2022
Developing novel therapeutics to treat people with chronic neutropenic disorders
X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company and a leader in the discovery and development of novel therapies for the treatment of diseases of the immune system via antagonism of the CXCR4 pathway, with a focus on rare diseases and those with limited treatment options.
Entry Price: 1.105
Exit Price: 1.81
bottom of page